Outbreaks & Infectious Disease
Antibiotic resistant organisms (such as MRSA and VRE)
-
MRSA and VRE are becoming increasingly common both in health care and community settings and require special considerations in the provision of care.
See also: Antibiotic Resistant Organism (ARO) Risk Factor-Based Screening Guidance for All Health Care Settings Screening Checklists (June 2024, PDF 303 KB).
Avian influenza
-
While human to human transmission risk is low, Public Health Ontario has published a guide to the Prevention and Management of Avian Influenza in Health Care Settings (PDF, 178 KB).
-
Summary of NACI statement of February 19, 2025: Rapid response on preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024
Bed bugs
-
Although bed bugs do not carry or transmit disease, they can result in an infestation. Certain precautions can be taken to halt their spread.
Candida auris
-
Candida auris: Now designated Disease of Public Health Significance by Public Health Ontario. Cases must be reported to your local public health unit.
More information on Candida auris is available from Public Health Ontario. See also: Antibiotic Resistant Organism (ARO) Risk Factor-Based Screening Guidance for All Health Care Settings Screening Checklists (June 2024, PDF 303 KB).
COVID-19
-
See the Ontario Respiratory Virus Tool for provincial surveillance data.
In May 2022, the CANCOVID-Preg team published a surveillance study including 6012 completed pregnancies between March 2020 and October 2021. Among the 6,012 cases of COVID-19 in pregnancy, 466 (7.75 per cent) required hospitalization and 121 (2.01 per cent) were admitted to an ICU. Compared with cases of infection in non pregnant, reproductive aged individuals, those who were pregnant were more likely to be hospitalized (relative risk, 2.65; 95% CI, 2.41-2.88), and more likely to need care in the ICU (relative risk, 5.46; 95% CI, 4.50-6.53). The data also demonstrated an increased risk of early labour for those who were infected with COVID-19 in pregnancy (relative risk, 1.63; 95% CI, 1.52-1.76).
Results from the 4th report of the CANCOVID-Preg study largely show positive pregnancy outcomes. Of 1821 reported pregnancy outcomes affected by COVID-19, there were 19 (1%) stillbirths and < 6 newborns who were tested for COVID-19 received a positive result. Importantly, in this sample, stillbirth rates were 10.6 per 1000 compared to 5.44 per 1000 in the general population (derived from CIHI-DAD 2020 data). Although the stillbirth estimate in our COVID-19 positive cases is slightly higher than the general population, the absolute numbers are still quite small. (Money 2021)
Of the 1769 cases with delivery and gestational age data, 87.1% occurred at term and 12.9% at preterm gestation. Of the 228 (12.1%) preterm infants, 34.6% were medically indicated preterm deliveries and 39.9% were spontaneous. This preterm birth rate is twice the rate of preterm birth in the general pregnant population. This is likely associated with severity of infection. (Money 2021; SOGC 2021)
Ebola virus disease
-
Rescinding Ebola virus disease directives (PDF, 137 KB).
Influenza
-
Influenza, including H1N1 and varying other strains is an annual concern and pregnant persons and newborns are at an increased risk of complications. The Public Health Agency of Canada influenza awareness resources can be displayed and shared in midwifery clinics.
-
See the Ontario Respiratory Virus Tool for surveillance data.
Measles
Measles has become more common globally, and as a result Ontario has seen an increase in measles rates and exposures.
-
Public Health Ontario (PHO) technical brief Interim IPAC Recommendations and Use of PPE for Care of Individuals with Suspect or Confirmed Measles (PDF, 292 KB) reviews clinical presentations of measles, infection prevention and control practices and vaccination recommendations for health-care workers.
-
PHO Updated epidemiological summary of measles cases, March 13, 2025 (PDF, 236 KB).
-
National Advisory Committee on Immunization (NACI), Summary of NACI statement of February 13, 2025: Updated recommendations on measles post-exposure prophylaxis.
-
PHO Technical Brief, Measles: Information for Health Care Providers, September 2024 (PDF, 259 KB).
-
PHO Measles IPAC Checklist for Clinics and Specimen Collection Centres, September 2024 (PDF, 449 KB).
-
Measles. Sarah E. Wilson, Marina I. Salvadori, Michelle Science. CMAJ Apr 2024, 196 (15) E524.
More information on measles is available from Public Health Ontario, including surveillance reports and a regularly updated list of exposure sites.
Clients with febrile and/or respiratory rash illness should be screened for risk factors over the phone (no/unknown immunity, contact with a known case, recent travel). Consider conducting any physical evaluation offsite or in a negative pressure room to minimize exposures. At a minimum, care providers should wear an N95 face mask and adhere to other IPAC best practices outlined in the technical brief.
Vaccination is the best way to prevent measles spread. The Canadian Immunization Guide contains details for pregnant and postpartum individuals. Refresh your clinic's vaccination resources using materials from the Canadian Association of Midwives (CAM). CAM members can log in to view the recorded webinar addressing vaccine hesitancy. Find more resources on client counselling from Immunize Canada.
Middle East Respiratory Coronavirus (MERS CoV) & Avian Influenza (H7N9)
-
Oct 11, 2017: Situational update on the avian influenza A(H7N9) virus and Middle East Respiratory Coronavirus (PDF, 137 KB), (French version)
Mpox (Monkeypox)
-
August 13 2024: Toronto Public Health urges eligible residents to get vaccinated against mpox as local cases continue to rise
-
November 2022: MOH Recommendations for the management of cases and contacts of monkeypox (MPX) in Ontario (PDF, 165 KB)
-
July 14, 2022: Fact Sheet: Monkeypox - Reference guide comparing monkeypox, chickenpox, and hand-foot-and-mouth disease (PDF, 135 KB)
-
July 14, 2022: MOH Health Care Provider Communication - Monkeypox (PDF,183 KB)
-
June 2022: Case Definitions and Other Disease Specific Information: Smallpox and Orthopoxviruses including Monkeypox (PDF, 2,805 KB)
-
May 28, 2022: MOH Q&A Monkeypox vaccination and post exposure prophylaxis (PDF, 1,206 KB)
-
May 20, 2022: CMOH Memo re Monkeypox (PDF, 265 KB)
-
May 2022: PHO Infection Prevention and Control (IPAC) Recommendations for Monkeypox in Health Care Settings (PDF, 1,115 KB)
Pertussis (Whooping cough)
-
Cases must be reported to your local public health unit.
-
December 2024: Public Health Ontario, Pertussis in Ontario: January 1 - November 30, 2024, Enhanced epidemiological summary (PDF, 352 KB)
Zika virus (ZIKV)
-
Dec 24, 2019: Zika virus prevention and treatment recommendations